Patterns of Distant Failure and Second Primary Cancers in Patients with Oropharyngeal Squamous Cell Carcinoma: Implications for Surveillance Methodology
- Authors
-
-
Edwin F. Crandley
Department of Radiation Oncology, University of Virginia, P.O. Box 800383, Charlottesville, VA 22908, USA -
David D. Wilson
Department of Radiation Oncology, University of Virginia, P.O. Box 800383, Charlottesville, VA 22908, USA -
Austin J. Sim
Department of Radiation Oncology, University of Virginia, P.O. Box 800383, Charlottesville, VA 22908, USA -
Neil Majithia
Department of Radiation Oncology, University of Virginia, P.O. Box 800383, Charlottesville, VA 22908, USA -
Edward B. Stelow
Department of Pathology, University of Virginia, P.O. Box 800904, Charlottesville, VA 22908, USA -
Mark J. Jameson
Department of Otolaryngology – Head and Neck Surgery, University of Virginia, P.O. Box 800713, Charlottesville, VA 22908, USA -
David C. Shonka Jr.
Department of Otolaryngology – Head and Neck Surgery, University of Virginia, P.O. Box 800713, Charlottesville, VA 22908, USA -
Asal S. Rahimi
Department of Radiation Oncology, University of Texas – Southwestern, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA -
Paul W. Read
Department of Radiation Oncology, University of Virginia, P.O. Box 800383, Charlottesville, VA 22908, USA
-
- Keywords:
- Oropharynx cancer, surveillance, survivorship care, distant metastasis, second primary cancer.
- Abstract
-
Background: We analyzed the pattern of distant metastasis (DM) and secondary primary cancers (SPC) in patients with oropharyngeal squamous cell carcinoma (OPSCC) to develop surveillance guidelines.
Methods: A retrospective review of 177 patients with OPSCC treated with intensity modulated radiation therapy ± chemotherapy between 2002 and 2012 was performed to characterize the rate, pattern, and timing of DM and SPC.
Results: Sixteen patients (9.0%) developed DM and 9 patients (5.1%) developed a SPC. Overall, 24/177 patients (13.6%) developed a DM and/or SPC for a total of 27 events. 92.6% (25/27) of events were detectable on physical exam and/or chest CT. p16+ patients developed DM later than p16- tumors (23.4 months versus 8.7 months).
Conclusions: Chest CT with physical examination detects the majority of DM and SPC in patients with OPSCC and would provide effective surveillance in these patients. A risk adapted surveillance strategy is proposed.
- Downloads
-
Download data is not yet available.
- References
-
Daly ME, Le QT, Maxim PG, et al. Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: Clinical outcomes and patterns of failure. Int J Radiat Oncol Biol Phys 2010; 76: 1339-46. http://dx.doi.org/10.1016/j.ijrobp.2009.04.006
Setton J, Caria N, Romanyshyn J, et al. Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: An update of the memorial sloan-kettering cancer center experience. Int J Radiat Oncol Biol Phys 2012; 82: 291-8. http://dx.doi.org/10.1016/j.ijrobp.2010.10.041
Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35. http://dx.doi.org/10.1056/NEJMoa0912217
Shonka DC Jr, Shoushtari AN, Thomas CY, et al. Predicting residual neck disease in patients with oropharyngeal squamous cell carcinoma treated with radiation therapy: Utility of p16 status. Arch Otolaryngol Head Neck Surg 2009; 135: 1126-32. http://dx.doi.org/10.1001/archoto.2009.153
Huang SH, Perez-Ordonez B, Weinreb I, et al. Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer. Oral Oncol 2013; 49: 79-85. http://dx.doi.org/10.1016/j.oraloncology.2012.07.015
Huang SH, Perez-Ordonez B, Liu FF, et al. Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 2012; 82: 276-83. http://dx.doi.org/10.1016/j.ijrobp.2010.08.031
Blanchard P, Baujat B, Holostenco V, et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour site. Radiother Oncol 2011; 100: 33-40. http://dx.doi.org/10.1016/j.radonc.2011.05.036
Denis F, Garaud P, Bardet E, et al. Final results of the 94-01 french head and neck oncology and radiotherapy group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 2004; 22: 69-76. http://dx.doi.org/10.1200/JCO.2004.08.021
Reimers N, Kasper HU, Weissenborn SJ, et al. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer 2007; 120: 1731-8. http://dx.doi.org/10.1002/ijc.22355
de Bree R, Deurloo EE, Snow GB, Leemans CR. Screening for distant metastases in patients with head and neck cancer. Laryngoscope 2000; 110(Pt 1): 397-401. http://dx.doi.org/10.1097/00005537-200003000-00012
Spector ME, Chinn SB, Rosko AJ, et al. Diagnostic modalities for distant metastasis in head and neck squamous cell carcinoma: Are we changing life expectancy? Laryngoscope 2012; 122: 1507-11. http://dx.doi.org/10.1002/lary.23264
National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011; 365: 395-409. http://dx.doi.org/10.1056/NEJMoa1102873
O'Sullivan B, Huang SH, Siu LL, et al. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol 2013; 31: 543-50. http://dx.doi.org/10.1200/JCO.2012.44.0164
Riaz N, Setton J, Tam M, et al. Recursive partition analysis identifies oropharyngeal cancer patients at high risk for distant metastasis. Int J Radiat Oncol Biol Phys 2012; 84: S482.
Head and neck cancer clinical practice guidelines version 2.2013
Lung cancer screening clinical practice guidelines version 1.2014
- Downloads
- Published
- 29-07-2014
- Issue
- Vol. 3 No. 3 (2014)
- Section
- Articles
How to Cite
Similar Articles
- Suresh Chandra Yadav, Dilip Dwivedy, Deciphering the Role of Mitochondrial Metabolic Reprogramming in the Progression of Clear Cell Renal Cell Carcinoma , Journal of Cancer Research Updates: Vol. 15 No. 2 (2026)
- Vladan Bajic, Lada Živkovic, Andrea Cabarkapa, Biljana Spremo Potparevic, 8-Cl-cAMP, The Old Dog with New Tricks: A Review , Journal of Cancer Research Updates: Vol. 4 No. 4 (2015)
- Niyati V. Thakkar, Anisha Chaudhary, Smiral Gameti, K. Ezhil Vendhan, Nittin Sharma, K.V. Jamuna, Rajesh Kumar Lenka, Metagenomic Analysis of the Oral Microbiome in Patients with Head and Neck Squamous Cell Carcinoma: A Case-Control Study , Journal of Cancer Research Updates: Vol. 15 No. 4 (2026)
- Patrick A. Riley, Epigenetic Carcinogenesis and Malignancy: The Significance of Migratory Potential , Journal of Cancer Research Updates: Vol. 12 (2023)
- Bhavisha Patel, Balasankar Karavadi, Ravindrasinh M. Rajput, Shivangi Gupta, Rajashree Panigrahi, P. Ravishankar, Saksham Sood, Honganur Raju Manjunath, Landscape of Targetable Genetic Alterations in Advanced Cholangiocarcinoma among Patients in Southeast Asia , Journal of Cancer Research Updates: Vol. 15 No. 3 (2026)
- Irene Ruiz, Freddy Fernando Durán, Carmen Sáez, Julián Sanz, Adela Pelayo, Fernando Moreno, Jorge Ruiz, Luis Ortega, Alejandro Pascual, HER2 Expression Discordance between Ductal Carcinoma In situ and Invasive Breast Carcinoma. How to Analyze Oncotype DX , Journal of Cancer Research Updates: Vol. 8 No. 1 (2019)
- Sara Wahab Tawfeeq, Jangi Shawkat Muhialdin, Idress Jarjess Ahmad, Ultrasound-Based Bladder Volume Assessment in Gynecological Radiotherapy: Agreement with CT/CBCT and Longitudinal Variation , Journal of Cancer Research Updates: Vol. 15 No. 4 (2026)
- Giovanni Luigi Capella, Do "Incidental Melanomas" Exist? If so, how many are they? High Time to Decide , Journal of Cancer Research Updates: Vol. 8 No. 1 (2019)
- Yao Li, Meng-Ning Wei, Wen-Ji Zhang, Zhi Shi, A HPLC-UV Method for the Quantification of Regorafenib in Tumor , Journal of Cancer Research Updates: Vol. 9 No. 1 (2020)
- R. Hsieh, M.L. Prasad, M.M.S. Nico, H. Tavares, A. Altemani, R.S.S. Macarenco, S.V. Lourenço, A Study of C-MYC, SOX10 and BCL-2 Proteins Expression in Head and Neck Mucosal Melanomas , Journal of Cancer Research Updates: Vol. 5 No. 4 (2016)
You may also start an advanced similarity search for this article.